SLC9A9 and glioblastoma: Strictly speaking, stem cells are capable of self-renewal as well as multilineage differentiation, therefore, a thorough evaluation of molecular and functional lineage and stem cell markers (13, 49) associated with NHE9 in GBM may be helpful.